…results — whether it be in investing or other fields. “In other words, investors might get the best performance from following simple stock screens to the letter, rather than using…
Search Results for: investing greats
"Cliff-Sensitive" Stocks with Upside
…He offers a handful of picks targeted by his Guru Strategies, each of which is based on the approach of a different investing great. Among them: defense firm General Dynamics….
Face Your Fiscal Cliff Fears
…consequences might not be as dire as many expect,” Reese wrties in his latest Forbes.com column. “A recent study by O’Shaughnessy Asset Management, the firm headed by quantitative investing guru…
Chemical Reactions for the Gurus
…which is based on the approach of a different investing great, to find some of the market’s most fundamentally sound chemical plays. Among the stocks he highlights: Illinois-based Stepan Company….
Fisher: Obama Isn't A "Market Killer"
…fear”, Fisher contends. And he says not to give in to fears. “Ideology is a dangerous bias in investing — blinding you to reality,” he writes. “Like or hate Obama’s…
Sonders Sees "Coiled Spring" Economy, But Concerned About Cliff
…and that positive action on the fiscal cliff could lead businesses, which have been wary of spending or investing, to change course. “I do believe there is a coiled spring…
How to Overcome Your Own Mind and Beat the Market
…right on a little over half of your picks, you will make nice money.” By using quantitative strategies when investing, Reese says investors can help keep emotion at bay and…
Knowing When to Fold 'em
In his bi-weekly Hot List newsletter, Validea CEO John Reese offers his take on the markets and investing. In the latest issue, John looks at a key but often overlooked…
Stocks For An Obama -- Or Romney -- Presidency
…offers five stocks that his Guru Strategies — each of which is based on the approach of a different investing great — are high on right now. Among them: Raven…
Pharma Firms for the Gurus
…of which is based on the approach of a different investing great, are finding some nice bargains in pharma firms right now. He looks at three of them, including Novartis,…